On Jan. 3, 2022, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to expand the use of a single booster dose to adolescents aged 12 through 15 years old. The Centers for Disease Control and Prevention (CDC) also updated their related recommendations on Jan. 5.
The updated EUA also shortens the time between the completion of the Pfizer-BioNTech primary series and the booster dose to at least five months and allows for a third primary series dose for certain immunocompromised children aged 5 through 11 years old.
This updated guidance only applies to the Pfizer-BioNTech vaccine and not the Moderna or Johnson & Johnson/Janssen vaccines. Adults 18 and older who received a Moderna vaccine are eligible for a booster shot at least six months after the completion of their primary series. For individuals who received the Johnson & Johnson/Janssen vaccine, a booster is recommended for everyone who was vaccinated at least two months ago.
First and second doses and booster shots are available from UTMB by appointment. Schedule your COVID vaccine online.
Additional information on the Emergency Use Authorizations for each vaccine are available online:
As the Omicron variant continues to surge in the communities we serve, it is especially important to get a booster dose at the recommended time to increase protection against serious illness. Thank you for your efforts to slow the spread of COVID-19.
Janak Patel, MD Director, Infection Control and Healthcare Epidemiology Professor, Pediatrics/Infectious Disease
Philip Keiser, MD Professor, Internal Medicine/Infectious Diseases Galveston County Health Authority UTMB COVID-19 Vaccination Preparedness Task Force Chair
This message was sent by the Office of Marketing & Communications on behalf of the UTMB COVID-19 Vaccination Preparedness Task Force.